by Alison Bass | Jul 5, 2011 | antipsychotic drugs, conflicts of interest, pharmaceutical industry, university industry collaboration
Harvard Medical School finally wrapped up its three-year-old investigation of Dr. Joseph Biederman and two colleagues accused of failing to disclose extensive financial conflicts of interest, with essentially a slap on the wrist. In 2008, Congressional investigators...
by Alison Bass | Jun 14, 2011 | pharmaceutical industry, Uncategorized, university industry collaboration
I was planning to blog about Pfizer’s new $100 million partnership with several Boston-area medical centers and its potential downsides. But before I could get around to doing that, I was invited to talk about the deal on WGBH-TV’s Greater Boston show...
